Remdesivir (ремдесивир)

[chuka_lis]

China will kickstart a phase III trial Feb. 3 to determine whether patients with 2019-nCoV can be treated with Gilead Sciences Inc.’s NUC inhibitor, remdesivir, which was originally developed for Ebola, four days after a U.S. patient was said to have recovered by using the drug candidate.
Итория лечения пациента из штата Вашингтон показала, что у

Comments

[seva_kasatkin]

Доброй среды!

[chuka_lis]

спасибо! и Вам -удачной..)